Humanigen CEO gives update on Covid-19 treatment

It’s shocking that more than 560,000 Americans have died from the coronavirus.

So, while the push to get people vaccinated is a national priority, another critical need is to find new treatments for the virus.

Joining us today with an update on current and some new Covid-19 treatment options was Dr. Cameron Durrant Chairman and CEO of Humanigen.

Dr. Durrant also has an MBA, and he leads a company that has just completed a phase three trial and will be requesting emergency use authorization for a new monoclonal antibody treatment called Lenzilumab or Lenz.

For more information, visit: Humanigen.com/lenzilumab

THIS SEGMENT IS SPONSORED BY HUMANIGEN.